Skip to main content
HLB SCIENCE Inc. logo

HLB SCIENCE Inc. — Investor Relations & Filings

Ticker · 343090 ISIN · KR7343090007 KO Professional, scientific and technical activities
Open in API
Filings indexed 187 across all filing types
Latest filing 2024-03-19 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 343090

About HLB SCIENCE Inc.

https://hlbscience.com/eng/index.php

HLB SCIENCE Inc. is a biopharmaceutical company specializing in the development of innovative drugs and diagnostics for infectious and immune-related diseases. The company's primary research focuses on creating therapeutics for sepsis, superbacteria infections, and Alzheimer's disease. Its key pipeline candidate for sepsis, DD-S052P, is a novel antibiotic designed to eliminate both bacteria and their associated endotoxins to mitigate cytokine storms. For Alzheimer's disease, HLB SCIENCE is advancing DD-A279, a treatment that modulates lipopolysaccharides (LPS) and gram-negative bacteria in the central nervous system. This therapeutic effort is complemented by the development of DD-A514, a diagnostic kit for the early detection of Alzheimer's.

Recent filings

Filing Released Lang Actions
주식매수선택권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the exercise of stock options (주식매수선택권 행사) by a company, resulting in the issuance of new shares. This type of corporate action, which involves changes to the company's capital structure through the issuance of new shares, falls under the category of Share Issue/Capital Change.
2024-03-19 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is titled '감사보고서 제출' (Submission of Audit Report) and provides a summary of the audit opinion, key financial figures, and the auditor's name. It is a regulatory filing announcing the submission of the audit report to the exchange, which fits the definition of an Audit Report / Information (AR) filing as it contains the specific audit results and financial data extracted from the audit process. FY 2023
2024-03-18 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for HLB Science, covering the fiscal year 2023 (2023.01.01-2023.12.31). It contains detailed company information, financial data, governance, and management discussions, which is the standard format for an Annual Report (10-K equivalent) in the South Korean regulatory framework (DART). FY 2023
2024-03-18 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for HLB Science. It contains the meeting agenda, details on voting procedures (including electronic voting), and management reference materials such as financial statements and business overviews. This document is a standard proxy statement/notice for an upcoming shareholder meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2024-03-08 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) for HLB Science. It outlines the date, location, and agenda items (financial statement approval, director/auditor appointments, and remuneration limits). This document is a standard proxy solicitation/notice of meeting sent to shareholders to inform them of the upcoming AGM and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2024-02-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership of Specific Securities by Executives and Major Shareholders'. This is a standard regulatory filing in South Korea (DART system) used by insiders or major shareholders to disclose changes in their shareholdings. This falls under the category of 'Director's Dealing' (DIRS) as it reports transactions or changes in ownership status by major shareholders/executives.
2024-02-16 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.